Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today reported its business update and consolidated financial results for the year ending December 31, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results